OKYO Pharma Ltd
NASDAQ:OKYO
Cash Flow Statement
Cash Flow Statement
OKYO Pharma Ltd
| Mar-2020 | Mar-2021 | Mar-2022 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(1)
|
(3)
|
(5)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
1
|
1
|
|
| Cash Interest Paid |
0
|
(0)
|
0
|
|
| Change in Working Capital |
0
|
1
|
(1)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
-30%
|
(4)
-220%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
0
|
(0)
|
(0)
|
|
| Other Items |
(0)
|
(0)
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+87%
|
(0)
+91%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
1
|
0
|
1
|
|
| Net Issuance of Debt |
(0)
|
6
|
0
|
|
| Other |
0
|
0
|
0
|
|
| Cash from Financing Activities |
1
N/A
|
6
+683%
|
1
-83%
|
|
| Change in Cash | ||||
| Net Change in Cash |
(0)
N/A
|
5
N/A
|
(3)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(1)
N/A
|
(1)
-30%
|
(4)
-219%
|
|